Year None202420232022202120202019201820172016 Date Latest Press Release May 4, 2017 Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City May 3, 2017 Eiger Announces U.S. IND Filing of Pegylated Interferon Lambda for Hepatitis Delta Virus Infection April 24, 2017 Eiger Announces Abstract and Presentation at 2017 Digestive Disease Week in Chicago April 21, 2017 Eiger Announces Additional Phase 2 Clinical Trial Results for Lonafarnib at The International Liver Congress™ 2017 April 18, 2017 Eiger Announces Industry Veteran Lisa Porter, M.D. to Lead Development of Exendin 9-39 for the Treatment of Post-Bariatric Hypoglycemia April 6, 2017 Eiger Announces Abstracts and Presentations of LOWR HDV Program at the European Association for the Study of the Liver (EASL) Meeting March 23, 2017 Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results January 30, 2017 Eiger BioPharmaceuticals to Present at BIO CEO & Investor Conference February 13th and Participate in SunTrust Robinson Humphrey Orphan Drug Day Conference February 14th January 4, 2017 Eiger Completes $25 Million Debt Financing with Oxford Finance January 3, 2017 Eiger Announces First Patient Dosed in Open-Label Extension of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension (PAH) Pagination First page « first Previous page ‹ previous … Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Next page next › Last page last »